EUVIMEDEUVIMED entdecken
Crossref

Lipoprotein lipids and apolipoproteins in primary immune thrombocytopenia: Results from a clinical characteristics and causal relationship verification, potential drug target identification by Mendelian randomization analyses

Yang Ou, Yanxia Zhan, Xia Shao, Pengcheng Xu, Lili Ji, Xibing Zhuang, Hao Chen, Yunfeng Cheng iD

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Yang Ou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Tumor Diagnosis and Therapy, Jinshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Apolipoprotein A-I, Purpura, Thrombocytopenic, Idiopathic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Key Subject Construction Program of Shanghai Health Administrative Authority, National Natural Science Foundation of China, Program of the Shanghai Academic/Technology Researcher leader.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary immune thrombocytopenia (ITP) is an acquired autoimmune disease. Cellular and systemic lipid metabolism plays a significant role in the regulation of immune cell activities. However, the role of lipoprotein lipids and apolipoproteins in ITP remains elusive. The automatic biochemistry analyser was used to measure the levels of serum total cholesterol (TC), triglyceride (TG), low‐density lipoprotein cholesterol (LDL‐C), high‐density lipoprotein cholesterol (HDL‐C), apolipoprotein A‐I (apoA‐I), apoB, apoE and lipoprotein a [LP(a)]. Genetic variants strongly associated with circulating lipoprotein lipids and apolipoproteins (LDL‐C, apoB, TG, HDL‐C and apoA‐I) were extracted to perform Mendelian randomization (MR) analyses. Finally, drug‐target MR and passive ITP mice model was used to investigate the potential druggable targets of ITP. Levels of HDL‐C, apoA‐I, decreased and LP(a) increased in ITP patients compared with healthy controls. Low HDL‐C was causally associated with ITP susceptibility. Through drug‐target MR and animal modelling, ABCA1 was identified as a potential target to design drugs for ITP. Our study found that lipid metabolism is related to ITP. The causative association between HDL‐C and the risk of ITP was also established. The study provided new evidence of the aetiology of ITP. ABCA1 might be a potential drug target for ITP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apolipoprotein A-IPurpura, Thrombocytopenic, IdiopathicAnimalsMiceHumansCholesterol, LDLLipidsMendelian Randomization AnalysisApolipoproteinsTriglyceridesCholesterol, HDL

Stichwörter der Autor:innen

ATP‐binding cassette transporter A1Mendelian randomizationhigh‐density lipoproteinlipid metabolismprimary immune thrombocytopenia

Substanzen

Apolipoprotein A-ICholesterol, LDLLipidsApolipoproteinsTriglyceridesCholesterol, HDL

Autor:innen und Institutionen

  • Center for Tumor Diagnosis and Therapy, Jinshan Hospital, Fudan University, Shanghai, China.
  • Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Thoracic Surgery, Zhongshan-Xuhui Hospital, Fudan University, Shanghai, China.
  • Institute of Clinical Science, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Hematology, Zhongshan Hospital Qingpu Branch, Fudan University, Shanghai, China.

ORCID-Profile: Yunfeng Cheng

Förderung

  • Key Subject Construction Program of Shanghai Health Administrative Authority
  • National Natural Science Foundation of China
  • Program of the Shanghai Academic/Technology Researcher leader
  • Shanghai Engineering Research Center of Tumor Multi-Target Gene Diagnosis
  • the Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Ou, Y., Zhan, Y., Shao, X., Xu, P., Ji, L., Zhuang, X., Chen, H., & Cheng, Y. (2024). Lipoprotein lipids and apolipoproteins in primary immune thrombocytopenia: Results from a clinical characteristics and causal relationship verification, potential drug target identification by Mendelian randomization analyses. British Journal of Haematology. https://doi.org/10.1111/bjh.19229

Vancouver

Ou Y, Zhan Y, Shao X, Xu P, Ji L, Zhuang X, et al. Lipoprotein lipids and apolipoproteins in primary immune thrombocytopenia: Results from a clinical characteristics and causal relationship verification, potential drug target identification by Mendelian randomization analyses. British Journal of Haematology. 2024. doi:10.1111/bjh.19229

BibTeX
@article{Ou2024,
  author = {Ou, Yang and Zhan, Yanxia and Shao, Xia and Xu, Pengcheng and Ji, Lili and Zhuang, Xibing and Chen, Hao and Cheng, Yunfeng},
  title = {Lipoprotein lipids and apolipoproteins in primary immune thrombocytopenia: Results from a clinical characteristics and causal relationship verification, potential drug target identification by Mendelian randomization analyses},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19229}
}
Kostenlos starten →